New research links arthritis to an increased risk of prostate cancer, highlighting the need for further studies on prevention ...

The sCD13 protein has been previously identified by a rheumatology research team at the University of Michigan as a powerful inducer of inflammation in multiple autoimmune disorders, such as ...

A new study finds that women with rheumatoid arthritis, lupus, or other autoimmune conditions have twice the risk of dying ...

Individuals with rheumatoid arthritis face a higher risk of hospitalization for heart failure and pulmonary edema, a new ...

Jeanine McGuire was diagnosed at 14 with rheumatoid arthritis, something she considered to be an old person’s disease. An ...

Understanding the subtypes of juvenile idiopathic arthritis can help adult and pediatric rheumatologists manage patients ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

Dr. Ho Sang Jung and his research team from the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science (KIMS), in collaboration with Seoul St. Mary's ...

Rheumatoid arthritis is less common than osteoarthritis, affecting around 514,000 Australians. It mostly impacts the wrists ...

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the ...

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...